Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Linezolid

Research Leaders

7 sponsors active, led by University of Louisville

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07792915Phase 2Not Yet Recruiting

A Clinical Trial of Resistant Potato Starch for Gut MDRO Decolonization

NCT01561469CompletedPrimary

Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

Showing all 2 trials

Research Network

Common Treatments

  • Linezolid1
  • Vancomycin1
  • Maltodextrin1
  • Resistant Potato Starch1

Active Sponsors

  • University of Louisville1
  • VA Office of Research and Development1
  • Summa Health System1
  • Sparrow Health System1
  • Pfizer1

Top Investigators

Related Conditions

  • Carbapenemresistant Enterobacteriaceae1
  • Clostridium Infections1
  • Vancomycinresistant Enterococci1
  • Asymptomatic Infections1
  • Hospitalacquired Pneumonia1

Activity Timeline